Key result
Type 1 diabetes was associated with a significant loss of bone marrow innervation, altered hematopoiesis, and increased central inflammation, which could be mitigated by minocycline in mice.
Why the study?
Does minocycline mitigate central inflammation and bone marrow-derived monocyte infiltration in type 1 diabetes?
Does minocycline mitigate central inflammation and bone marrow-derived monocyte infiltration in type 1 diabetes?
Targeting central inflammation with agents like minocycline may help manage microvascular complications in type 1 diabetes by mitigating bone marrow neuropathy and altered hematopoiesis.
Answers are grounded in this paper and cite their sources.
Minocycline effects in diabetic mice should not yet change practice; hypothesis-generating for central inflammation targeting in human type 1 diabetes complications.
By using pseudorabies virus expressing green fluorescence protein, we found that efferent bone marrow-neural connections trace to sympathetic centers of the central nervous system in normal mice. However, this was markedly reduced in type 1 diabetes, suggesting a significant loss of bone marrow innervation. This loss of innervation was associated with a change in hematopoiesis toward generation of more monocytes and an altered diurnal release of monocytes in rodents and patients with type 1 diabetes. In the hypothalamus and granular insular cortex of mice with type 1 diabetes, bone marrow-derived microglia/macrophages were activated and found at a greater density than in controls. Infiltration of CD45(+)/CCR2(+)/GR-1(+)/Iba-1(+) bone marrow-derived monocytes into the hypothalamus could be mitigated by treatment with minocycline, an anti-inflammatory agent capable of crossing the blood-brain barrier. Our studies suggest that targeting central inflammation may facilitate management of microvascular complications.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2013) studied Type 1 diabetes. Type 1 diabetes vs. Normal controls was evaluated on Bone marrow innervation and central inflammation. Type 1 diabetes was associated with a significant loss of bone marrow innervation, altered hematopoiesis, and increased central inflammation, which could be mitigated by minocycline in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: